Literatures

Primary Site >> Stomach Cancer

Gene >> ERCC1

1.
Journal:	J Clin Oncol. 1998 Jan;16(1):309-16.
Title:	ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy.
Author:	Metzger, R\|Leichman, C G\|Danenberg, K D\|Danenberg, P V\|Lenz, H J\|Hayashi, K\|Groshen, S\|Salonga, D\|Cohen, H\|Laine, L\|Crookes, P\|Silberman, H\|Baranda, J\|Konda, B\|Leichman, L
PMID:	9440758

2.
Journal:	Cancer Treat Rev. 1998 Oct;24(5):331-44.
Title:	Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy.
Author:	Reed, E
PMID:	9861196

3.
Journal:	Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1513-30.
Title:	Polymorphisms in DNA repair genes and associations with cancer risk.
Author:	Goode, Ellen L\|Ulrich, Cornelia M\|Potter, John D
PMID:	12496039

4.
Journal:	Suppl Tumori. 2003 Sep-Oct;2(5):S19-22.
Title:	Pharmacogenetics of stomach cancer.
Author:	Toffoli, Giuseppe\|Cecchin, Erika
PMID:	12914384

5.
Journal:	Clin Cancer Res. 2005 Apr 15;11(8):3025-31.
Title:	Combined GADD45A and thymidine phosphorylase expression levels predict response and survival of neoadjuvant-treated gastric cancer patients.
Author:	Napieralski, Rudolf\|Ott, Katja\|Kremer, Markus\|Specht, Katja\|Vogelsang, Holger\|Becker, Karen\|Muller, Martina\|Lordick, Florian\|Fink, Ulrich\|Rudiger Siewert, Jorg\|Hofler, Heinz\|Keller, Gisela
PMID:	15837757

6.
Journal:	J Clin Oncol. 2006 Apr 20;24(12):1883-91.
Title:	Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy.
Author:	Ruzzo, Annamaria\|Graziano, Francesco\|Kawakami, Kazuyuki\|Watanabe, Go\|Santini, Daniele\|Catalano, Vincenzo\|Bisonni, Renato\|Canestrari, Emanuele\|Ficarelli, Rita\|Menichetti, Ettore Tito\|Mari, Davide\|Testa, Enrica\|Silva, Rosarita\|Vincenzi, Bruno\|Giordani, Paol
PMID:	16622263

7.
Journal:	Adv Exp Med Biol. 2006;587:115-20.
Title:	Prediction of response to neoadjuvant chemotherapy in carcinomas of the upper gastrointestinal tract.
Author:	Hofler, Heinz\|Langer, Rupert\|Ott, Katja\|Keller, Gisela
PMID:	17163161

8.
Journal:	Cancer Res Treat. 2006 Feb;38(1):19-24.
Title:	Increased ERCC expression correlates with improved outcome of patients treated with cisplatin as an adjuvant therapy for curatively resected gastric cancer.
Author:	Baek, Sun Kyung\|Kim, Si-Young\|Lee, Jae Jin\|Kim, Yoon Wha\|Yoon, Hwi Joong\|Cho, Kyung Sam
PMID:	19771254

9.
Journal:	Cancer Chemother Pharmacol. 2007 Oct;60(5):703-11.
Title:	Synergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on chemotherapeutic agent-associated genes in human gastric cancer cell lines.
Author:	Wei, Jia\|Liu, Baorui\|Wang, Lifeng\|Qian, Xiaoping\|Ding, Yitao\|Yu, Lixia
PMID:	17256130

10.
Journal:	Ann Oncol. 2007 Mar;18(3):504-9.
Title:	Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer.
Author:	Kwon, H-C\|Roh, M S\|Oh, S Y\|Kim, S-H\|Kim, M C\|Kim, J-S\|Kim, H-J
PMID:	17322540

11.
Journal:	Recent Results Cancer Res. 2007;176:33-6.
Title:	Prediction of response to neoadjuvant chemotherapy in carcinomas of the upper gastrointestinal tract.
Author:	Hofler, Heinz\|Langer, Rupert\|Ott, Katja\|Keller, Gisela
PMID:	17607914

12.
Journal:	Clin Chem Lab Med. 2007;45(7):822-8.
Title:	Polymorphisms in genes involved in DNA repair and metabolism of xenobiotics in individual susceptibility to sporadic diffuse gastric cancer.
Author:	Ruzzo, Annamaria\|Canestrari, Emanuele\|Maltese, Paolo\|Pizzagalli, Francesca\|Graziano, Francesco\|Santini, Daniele\|Catalano, Vincenzo\|Ficarelli, Rita\|Mari, Davide\|Bisonni, Renato\|Giordani, Paolo\|Giustini, Lucio\|Lippe, Paolo\|Silva, Rosarita\|Mattioli, Rodolfo\|
PMID:	17617021

13.
Journal:	Br J Cancer. 2008 Feb 26;98(4):832-9.
Title:	Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer.
Author:	Matsubara, J\|Nishina, T\|Yamada, Y\|Moriwaki, T\|Shimoda, T\|Kajiwara, T\|Nakajima, T E\|Kato, K\|Hamaguchi, T\|Shimada, Y\|Okayama, Y\|Oka, T\|Shirao, K
PMID:	18231104

14.
Journal:	Br J Cancer. 2008 Apr 22;98(8):1398-402.
Title:	ERCC1 mRNA levels and survival of advanced gastric cancer patients treated with a modified FOLFOX regimen.
Author:	Wei, J\|Zou, Z\|Qian, X\|Ding, Y\|Xie, L\|Sanchez, J J\|Zhao, Y\|Feng, J\|Ling, Y\|Liu, Y\|Yu, L\|Rosell, R\|Liu, B
PMID:	18362936

15.
Journal:	BMC Cancer. 2008 Apr 11;8:97.
Title:	ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel.
Author:	Wang, Lifeng\|Wei, Jia\|Qian, Xiaoping\|Yin, Haitao\|Zhao, Yang\|Yu, Lixia\|Wang, Tingting\|Liu, Baorui
PMID:	18402708

16.
Journal:	Cancer. 2008 Jun 15;112(12):2765-73.
Title:	Thymidylate synthase in situ protein expression and survival in stage I nonsmall-cell lung cancer.
Author:	Zheng, Zhong\|Li, Xueli\|Schell, Michael J\|Chen, Tingan\|Boulware, David\|Robinson, Lary\|Sommers, Eric\|Bepler, Gerold
PMID:	18442042

17.
Journal:	Anticancer Res. 2008 Jul-Aug;28(4B):2087-92.
Title:	Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
Author:	Tozawa, Katsuyuki\|Oshima, Tadayuki\|Kobayashi, Takehiko\|Yamamoto, Noriyasu\|Hayashi, Chizuko\|Matsumoto, Takayuki\|Miwa, Hiroto
PMID:	18751380

18.
Journal:	World J Gastroenterol. 2008 Nov 7;14(41):6401-7.
Title:	ERCC1 polymorphism, expression and clinical outcome of oxaliplatin-based adjuvant chemotherapy in gastric cancer.
Author:	Huang, Zhao-Hui\|Hua, Dong\|Du, Xiang\|Li, Li-Hua\|Mao, Yong\|Liu, Zhi-Hui\|Song, Ming-Xu\|Zhou, Xi-Ke
PMID:	19009659

19.
Journal:	Zhonghua Bing Li Xue Za Zhi. 2008 Aug;37(8):551-2.
Title:	[ERCC1 mRNA expression levels and outcome of gastric cancer patients receiving oxaliplatin-based chemotherapy].
Author:	Wei, Jia\|Zou, Zheng-yun\|Qian, Xiao-ping\|Wang, Li-feng\|Yu, Li-xia\|Liu, Bao-rui
PMID:	19094468

20.
Journal:	Cancer Chemother Pharmacol. 2009 Oct;64(5):1001-7.
Title:	Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy.
Author:	Huang, Zhao-Hui\|Hua, Dong\|Du, Xiang
PMID:	19247656

21.
Journal:	Br J Cancer. 2009 Mar 10;100(5):732-8.
Title:	Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival.
Author:	Kim, J-S\|Kim, M-A\|Kim, T M\|Lee, S-H\|Kim, D-W\|Im, S-A\|Kim, T-Y\|Kim, W H\|Yang, H-K\|Heo, D S\|Bang, Y-J\|Lee, K-U\|Choe, K-J\|Kim, N K
PMID:	19259093

22.
Journal:	J Clin Oncol. 2009 Jun 10;27(17):2863-73.
Title:	Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: a study of the arbeitsgemeinschaft internistische onkologie.
Author:	Goekkurt, Eray\|Al-Batran, Salah-Eddin\|Hartmann, Jorg T\|Mogck, Ulrike\|Schuch, Gunter\|Kramer, Michael\|Jaeger, Elke\|Bokemeyer, Carsten\|Ehninger, Gerhard\|Stoehlmacher, Jan
PMID:	19332728

23.
Journal:	Oncol Rep. 2009 Jul;22(1):127-36.
Title:	Comprehensive analysis of excision repair complementation group 1, glutathione S-transferase, thymidylate synthase and uridine diphosphate glucuronosyl transferase 1A1 polymorphisms predictive for treatment outcome in patients with advanced gastric cancer
Author:	Seo, Bong-Gun\|Kwon, Hyuk-Chan\|Oh, Sung Yong\|Lee, Suee\|Kim, Sung-Gun\|Kim, Sung-Hyun\|Han, Hoon\|Kim, Hyo-Jin
PMID:	19513514

24.
Journal:	Eur J Cancer. 2009 Dec;45(18):3326-35.
Title:	CyclinD1 and interleukin-1 receptor antagonist polymorphisms are associated with prognosis in neoadjuvant-treated gastric carcinoma.
Author:	Stocker, Gertraud\|Ott, Katja\|Henningsen, Nils\|Becker, Karen\|Hapfelmeier, Alexander\|Lordick, Florian\|Hois, Stefan\|Plaschke, Susanne\|Hofler, Heinz\|Keller, Gisela
PMID:	19822419

25.
Journal:	Cancer Chemother Pharmacol. 2010 May;65(6):1009-21.
Title:	A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer.
Author:	Bamias, Aristotelis\|Karina, M\|Papakostas, P\|Kostopoulos, I\|Bobos, M\|Vourli, G\|Samantas, E\|Christodoulou, Ch\|Pentheroudakis, G\|Pectasides, D\|Dimopoulos, M A\|Fountzilas, G
PMID:	20130877

26.
Journal:	Cancer Sci. 2010 May;101(5):1247-54.
Title:	BRCA1 and XRCC1 polymorphisms associated with survival in advanced gastric cancer treated with taxane and cisplatin.
Author:	Shim, Hyun Jeong\|Yun, Joo Young\|Hwang, Jun Eul\|Bae, Woo Kyun\|Cho, Sang Hee\|Lee, Ji Hee\|Kim, Hee Nam\|Shin, Min Ho\|Kweon, Sun Seog\|Lee, Jae Hyuk\|Kim, Hyeoung Joon\|Chung, Ik Joo
PMID:	20331623

27.
Journal:	Cancer Invest. 2010 Dec;28(10):1038-47.
Title:	The sequence-dependent cytotoxic effect of trastuzumab in combination with 5-Fluorouracil or cisplatin on gastric cancer cell lines.
Author:	Li, Xiao-Ling\|Yi, Shao-Qiong\|Xu, Jian-Ming\|Zhang, Yang\|Yingying-Feng\|Chen, Wei\|Song, San-Tai
PMID:	20590442

28.
Journal:	Asian Pac J Cancer Prev. 2010;11(1):181-5.
Title:	Prognostic value of excision repair cross-complementing gene 1 expression for cisplatin-based chemotherapy in advanced gastric cancer.
Author:	Ozkan, Metin\|Akbudak, Ismail Hakki\|Deniz, Kemal\|Dikilitas, Mustafa\|Dogu, Gamze Gokoz\|Berk, Veli\|Karaca, Halit\|Er, Ozlem\|Altinbas, Mustafa
PMID:	20593954

29.
Journal:	Cancer Res Treat. 2010 Jun;42(2):101-6.
Title:	Predictive value of the ERCC1 expression for treatment response and survival in advanced gastric cancer patients receiving cisplatin-based first-line chemotherapy.
Author:	Yun, Jina\|Kim, Kyoung-Mee\|Kim, Seung Tae\|Kim, Jung-Hoon\|Kim, Jung A\|Kong, Jee Hyun\|Lee, Soo Hyeon\|Won, Young-Woong\|Sun, Jong-Mu\|Lee, Jeeyun\|Park, Se Hoon\|Park, Joon Oh\|Park, Young Suk\|Lim, Ho Yeong\|Kang, Won Ki
PMID:	20622964

30.
Journal:	Mutagenesis. 2010 Nov;25(6):569-75.
Title:	Polymorphic DNA repair and metabolic genes: a multigenic study on gastric cancer.
Author:	Palli, Domenico\|Polidoro, Silvia\|D'Errico, Mariarosaria\|Saieva, Calogero\|Guarrera, Simonetta\|Calcagnile, Angelo S\|Sera, Francesco\|Allione, Alessandra\|Gemma, Simonetta\|Zanna, Ines\|Filomena, Alessandro\|Testai, Emanuela\|Caini, Saverio\|Moretti, Renato\|Gomez-M
PMID:	20817763

31.
Journal:	Int J Oncol. 2010 Nov;37(5):1219-28.
Title:	Expression profiling and long lasting responses to chemotherapy in metastatic gastric cancer.
Author:	Lo Nigro, Cristiana\|Monteverde, Martino\|Riba, Michela\|Lattanzio, Laura\|Tonissi, Federica\|Garrone, Ornella\|Heouaine, Abdelhamid\|Gallo, Fabio\|Ceppi, Marcello\|Borghi, Felice\|Comino, Alberto\|Merlano, Marco
PMID:	20878069

32.
Journal:	Zhonghua Zhong Liu Za Zhi. 2010 Jul;32(7):515-9.
Title:	[Association between genetic polymorphisms of ERCC1, XRCC1, GSTP1 and survival of advanced gastric cancer patients treated with oxaliplatin/5-Fu-based chemotherapy].
Author:	Liang, Jun\|Li, Qing-fang\|Yao, Ru-yong\|Lu, Hong-ying\|Jiang, Jian\|Sun, Ying-ying\|Song, Shan-ai\|Jiang, Tao
PMID:	21029695

33.
Journal:	Exp Ther Med. 2010 Mar;1(2):331-336.
Title:	Gene expression and effects of orally active derivatives of fluoropyrimidine on gastric and colorectal cancer.
Author:	Arakawa, Satoshi\|Ozawa, Soji\|Kawase, Jin\|Oshima, Hisanori\|Nagata, Hidetoshi\|Atsuta, Koji\|Umemoto, Shunji
PMID:	22993546

34.
Journal:	Dig Dis Sci. 2011 Jan;56(1):131-8.
Title:	Bax predicts outcome in gastric cancer patients treated with 5-fluorouracil, leucovorin, and oxaliplatin palliative chemotherapy.
Author:	Jeong, Seong Hyun\|Han, Jae Ho\|Kim, Jang Hee\|Ahn, Mi Sun\|Hwang, Yoon Ho\|Lee, Hyun Woo\|Kang, Seok Yun\|Park, Joon Seong\|Choi, Jin-Hyuk\|Lee, Kwang Jae\|Sheen, Seung Soo\|Lim, Ho-Yeong
PMID:	20503071

35.
Journal:	Biomarkers. 2011 Feb;16(1):74-82.
Title:	Clinicopathologic significance of ERCC1, thymidylate synthase and glutathione S-transferase P1 expression for advanced gastric cancer patients receiving adjuvant 5-FU and cisplatin chemotherapy.
Author:	Kim, Ki Han\|Kwon, Hyuk-Chan\|Oh, Sung Yong\|Kim, Sung Hyun\|Lee, Suee\|Kwon, Kyung A\|Jang, Jin Seok\|Kim, Min Chan\|Kim, Su-Jin\|Kim, Hyo-Jin
PMID:	21133646

36.
Journal:	Zhonghua Yi Xue Za Zhi. 2011 Jan 25;91(4):256-9.
Title:	[Predictive values of platinum-related gene polymorphisms in gastric cancer patients on oxaliplatin-based adjuvant chemotherapy].
Author:	Liu, Yong-ping\|Ling, Yang\|Zhang, Ya-ping\|Liu, Bao-rui
PMID:	21418871

37.
Journal:	Cancer Lett. 2011 Aug 1;307(1):47-52.
Title:	A FGFR2 inhibitor, Ki23057, enhances the chemosensitivity of drug-resistant gastric cancer cells.
Author:	Qiu, Hong\|Yashiro, Masakazu\|Zhang, Xiaotian\|Miwa, Atsushi\|Hirakawa, Kosei
PMID:	21482024

38.
Journal:	Chin J Cancer Res. 2011 Dec;23(4):288-94.
Title:	Expressions of Thymidylate Synthase,Thymidine Phosphorylase, Class III beta-tubulin, and Excision Repair Cross-complementing Group 1predict Response in Advanced Gastric Cancer Patients Receiving Capecitabine Plus Paclitaxel or Cisplatin.
Author:	Lu, Ming\|Gao, Jing\|Wang, Xi-Cheng\|Shen, Lin
PMID:	23358102

39.
Journal:	Cancer Lett. 2012 Aug 28;321(2):128-36.
Title:	Sunitinib synergizes the antitumor effect of cisplatin via modulation of ERCC1 expression in models of gastric cancer.
Author:	Yoon, Young-Kwang\|Im, Seock-Ah\|Min, Ahrum\|Kim, Hwang-Phill\|Hur, Hyung-Seok\|Lee, Kyung-Hun\|Han, Sae-Won\|Song, Sang-Hyun\|Youn Oh, Do\|Kim, Tae-You\|Kim, Woo Ho\|Bang, Yung-Jue
PMID:	22266184

40.
Journal:	Cancer Biother Radiopharm. 2012 Jun;27(5):299-306.
Title:	Enhancement of anticancer efficacy of chemotherapeutics by gambogic acid against gastric cancer cells.
Author:	Zou, Zheng-Yun\|Wei, Jia\|Li, Xiao-Lin\|Yu, Li-Xia\|Wang, Ting-Ting\|Qian, Xiao-Ping\|Liu, Bao-Rui
PMID:	22444164

41.
Journal:	BMC Gastroenterol. 2012 Sep 29;12:137.
Title:	Polymorphisms in ERCC1, GSTs, TS and MTHFR predict clinical outcomes of gastric cancer patients treated with platinum/5-Fu-based chemotherapy: a systematic review.
Author:	Wang, Zhen\|Chen, Jun-qiang\|Liu, Jin-lu\|Qin, Xin-gan\|Huang, Yuan
PMID:	23020798

42.
Journal:	PLoS One. 2012;7(11):e49308.
Title:	Polymorphisms in ERCC1 and XPF genes and risk of gastric cancer in an eastern Chinese population.
Author:	He, Jing\|Xu, Yu\|Qiu, Li-Xin\|Li, Jin\|Zhou, Xiao-Yan\|Sun, Meng-Hong\|Wang, Jiu-Cun\|Yang, Ya-Jun\|Jin, Li\|Wei, Qing-Yi\|Wang, Yanong
PMID:	23166636

43.
Journal:	Asian Pac J Cancer Prev. 2012;13(11):5619-25.
Title:	Role of integrin-linked kinase in multi-drug resistance of human gastric carcinoma SGC7901/DDP cells.
Author:	Song, Wei\|Jiang, Rui\|Zhao, Chun-Ming
PMID:	23317227

44.
Journal:	Cancer Chemother Pharmacol. 2013 Mar;71(3):789-97.
Title:	A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker.
Author:	Hirakawa, Masahiro\|Sato, Yasushi\|Ohnuma, Hiroyuki\|Takayama, Tetsuji\|Sagawa, Tamotsu\|Nobuoka, Takayuki\|Harada, Keisuke\|Miyamoto, Hiroshi\|Sato, Yasuhiro\|Takahashi, Yasuo\|Katsuki, Shinich\|Hirayama, Michiaki\|Takahashi, Minoru\|Ono, Michihiro\|Maeda, Masahiro\|Ta
PMID:	23338051

45.
Journal:	Cancer Chemother Pharmacol. 2013 Apr;71(4):921-8.
Title:	Correlation between expressions of ERCC1/TS mRNA and effects of gastric cancer to chemotherapy in the short term.
Author:	Chen, Liqi\|Li, Guoli\|Li, Jieshou\|Fan, Chaogang\|Xu, Jian\|Wu, Bo\|Liu, Kun\|Zhang, Caihua
PMID:	23355039

46.
Journal:	Oncol Lett. 2013 Mar;5(3):935-942.
Title:	The effects of ERCC1 expression levels on the chemosensitivity of gastric cancer cells to platinum agents and survival in gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy.
Author:	Liu, Yong-Ping\|Ling, Yang\|Qi, Qiu-Feng\|Zhang, Ya-Ping\|Zhang, Chang-Song\|Zhu, Chang-Tai\|Wang, Mei-Hua\|Pan, Yao-Dong
PMID:	23426424

47.
Journal:	J Transl Med. 2013 Mar 22;11:73.
Title:	A three-gene signature as potential predictive biomarker for irinotecan sensitivity in gastric cancer.
Author:	Shen, Jie\|Wei, Jia\|Wang, Hao\|Yue, Guofeng\|Yu, Lixia\|Yang, Yang\|Xie, Li\|Zou, Zhengyun\|Qian, Xiaoping\|Ding, Yitao\|Guan, Wenxian\|Liu, Baorui
PMID:	23517622

48.
Journal:	Mol Med Rep. 2013 Jun;7(6):1904-11.
Title:	Genetic polymorphisms of ERCC1118, XRCC1399 and GSTP1105 are associated with the clinical outcome of gastric cancer patients receiving oxaliplatinbased adjuvant chemotherapy.
Author:	Liu, Yong-Ping\|Ling, Yang\|Qi, Qiu-Feng\|Zhang, Ya-Ping\|Zhang, Chang-Song\|Zhu, Chang-Tai\|Wang, Mei-Hua\|Pan, Yao-Dong
PMID:	23604281

49.
Journal:	Cancer Chemother Pharmacol. 2013 Jul;72(1):159-65.
Title:	ERCC1 predicts outcome in patients with gastric cancer treated with adjuvant cisplatin-based chemotherapy.
Author:	De Dosso, Sara\|Zanellato, Elena\|Nucifora, Martina\|Boldorini, Renzo\|Sonzogni, Angelica\|Biffi, Roberto\|Fazio, Nicola\|Bucci, Eraldo\|Beretta, Ottavio\|Crippa, Stefano\|Saletti, Piercarlo\|Frattini, Milo
PMID:	23645290

50.
Journal:	Mutagenesis. 2013 Jul;28(4):441-6.
Title:	A genetic variant in ERCC2 is associated with gastric cancer prognosis in a Chinese population.
Author:	Chu, Haiyan\|Gu, Dongying\|Xu, Ming\|Xu, Zhi\|Gong, Yonglin\|Gong, Weida\|Tang, Yongfei\|Zhou, Jianwei\|Tong, Na\|Zhang, Zhengdong\|Chen, Jinfei\|Wang, Meilin
PMID:	23680703

51.
Journal:	Cancer. 2013 Sep 1;119(17):3242-50.
Title:	Differential expression and prognostic value of ERCC1 and thymidylate synthase in resected gastric adenocarcinoma.
Author:	Squires, Malcolm H 3rd\|Fisher, Sarah B\|Fisher, Kevin E\|Patel, Sameer H\|Kooby, David A\|El-Rayes, Bassel F\|Staley, Charles A 3rd\|Farris, Alton B 3rd\|Maithel, Shishir K
PMID:	23719746

52.
Journal:	PLoS One. 2013 Jun 7;8(6):e65164.
Title:	Synergistic anticancer effects of polyphyllin I and evodiamine on freshly-removed human gastric tumors.
Author:	Yue, Guofeng\|Wei, Jia\|Qian, Xiaoping\|Yu, Lixia\|Zou, Zhengyun\|Guan, Wenxian\|Wang, Hao\|Shen, Jie\|Liu, Baorui
PMID:	23762305

53.
Journal:	Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013 Jun;38(6):582-9.
Title:	[Effect of TUBB3, TS and ERCC1 mRNA expression on chemoresponse and clinical outcome of advanced gastric cancer by multiplex branched-DNA liquid chip technology].
Author:	Huang, Jin\|Hu, Huabin\|Xie, Yangchun\|Tang, Youhong\|Liu, Wei\|Zhong, Meizuo
PMID:	23828702

54.
Journal:	Ann Oncol. 2013 Oct;24(10):2560-5.
Title:	Impact of excision repair cross-complementing gene 1 (ERCC1) on the outcomes of patients with advanced gastric cancer: correlative study in Japan Clinical Oncology Group Trial JCOG9912.
Author:	Yamada, Y\|Boku, N\|Nishina, T\|Yamaguchi, K\|Denda, T\|Tsuji, A\|Hamamoto, Y\|Konishi, K\|Tsuji, Y\|Amagai, K\|Ohkawa, S\|Fujita, Y\|Nishisaki, H\|Kawai, H\|Takashima, A\|Mizusawa, J\|Nakamura, K\|Ohtsu, A
PMID:	23884439

55.
Journal:	PLoS One. 2013 Sep 2;8(9):e71994.
Title:	ERCC1 and ERCC2 variants predict survival in gastric cancer patients.
Author:	Li, Yangkai\|Liu, Zhensheng\|Liu, Hongliang\|Wang, Li-E\|Tan, Dongfeng\|Ajani, Jaffer A\|Wei, Qing-Yi
PMID:	24023723

56.
Journal:	BMC Cancer. 2013 Sep 23;13:431.
Title:	Class III beta-tubulin is a predictive marker for taxane-based chemotherapy in recurrent and metastatic gastric cancer.
Author:	Hwang, Jun-Eul\|Hong, Ji-Yun\|Kim, Karham\|Kim, Seung-Hun\|Choi, Won-Young\|Kim, Min-Jee\|Jung, Sung-Hoon\|Shim, Hyun-Jeong\|Bae, Woo-Kyun\|Hwang, Eu-Chang\|Lee, Kyung-Hwa\|Lee, Jae-Hyuk\|Cho, Sang-Hee\|Chung, Ik-Joo
PMID:	24053422

57.
Journal:	J Cancer Res Ther. 2013 Jul-Sep;9(3):410-5.
Title:	Excision repair cross-complementation group 1 codon 118 polymorphism, micro ribonucleic acid and protein expression, clinical outcome of the advanced gastric cancer response to first-line FOLFOX-4 in Qinghai-Tibetan plateau population.
Author:	Qi, Yu-Juan\|Cui, Sen\|Yang, Ying-Zhong\|Han, Jing-Qi\|Cai, Bao-Jia\|Sheng, Cun-Fang\|Ma, Yan\|Wuren, Tana\|Ge, Ri-Li
PMID:	24125975

58.
Journal:	Asian Pac J Cancer Prev. 2013;14(9):5507-12.
Title:	DNA repair capacity in peripheral blood lymphocytes predicts efficacy of platinum-based chemotherapy in patients with gastric cancer.
Author:	Zhang, Yi-Yin\|Gu, Kang-Sheng
PMID:	24175850

59.
Journal:	Cell Biol Int. 2014 Apr;38(4):502-10.
Title:	PEITC reverse multi-drug resistance of human gastric cancer SGC7901/DDP cell line.
Author:	Tang, Tao\|Song, Xin\|Liu, Yu-Fen\|Wang, Wen-Yue
PMID:	23956061

60.
Journal:	Anticancer Drugs. 2014 Mar;25(3):315-22.
Title:	Trastuzumab and oxaliplatin exhibit a synergistic antitumor effect in HER2-postive gastric cancer cells.
Author:	Ding, Xiaodi\|Qu, Xiujuan\|Fan, Yibo\|Che, Xiaofang\|Qu, Jinglei\|Xu, Ling\|Liu, Jing\|Liu, Yunpeng
PMID:	24300914

61.
Journal:	Tumour Biol. 2014 Apr;35(4):2941-8.
Title:	Influence of ERCC1 and ERCC4 polymorphisms on response to prognosis in gastric cancer treated with FOLFOX-based chemotherapy.
Author:	Lu, Zheng-mao\|Luo, Tian-hang\|Nie, Ming-ming\|Fang, Guo-en\|Ma, Li-ye\|Xue, Xu-chao\|Wei, Guo\|Ke, Chong-we\|Bi, Jian-wei
PMID:	24318989

62.
Journal:	Gene. 2014 Mar 10;537(2):238-44.
Title:	A nonsense mutation in the Xeroderma pigmentosum complementation group F (XPF) gene is associated with gastric carcinogenesis.
Author:	Wei, Zhong-Hua\|Guo, Wen-Huan\|Wu, Jun\|Suo, Wen-Hao\|Fu, Guo-Hui
PMID:	24412486

63.
Journal:	Zhongguo Zhong Xi Yi Jie He Za Zhi. 2014 Feb;34(2):224-9.
Title:	[Synergistic interaction between melittin and chemotherapeutic agents and their possible mechanisms: an experimental research].
Author:	Wang, Rui-Ping\|Huang, Shu-Ran\|Zhou, Jin-Yong\|Zou, Xi
PMID:	24672950

64.
Journal:	Mol Med Rep. 2014 Jun;9(6):2423-8.
Title:	ERCC1 siRNA ameliorates drug resistance to cisplatin in gastric carcinoma cell lines.
Author:	Li, Wei\|Jie, Zhigang\|Li, Zhengrong\|Liu, Yi\|Gan, Quan\|Mao, Yiqiu\|Wang, Xuemin
PMID:	24699918

65.
Journal:	Tumour Biol. 2014 Aug;35(8):7569-74.
Title:	Association of DNA repair gene polymorphisms with response to chemotherapy and prognosis of gastric cancer in a Chinese population.
Author:	Li, Junkai\|Zuo, Xiaoyan\|Lv, Xiaoyan\|Kong, Fanjun\|Xu, Wen\|Yang, Shujuan
PMID:	24793015

66.
Journal:	J Surg Oncol. 2014 Sep;110(3):302-6.
Title:	Molecular profiling in gastric cancer: examining potential targets for chemotherapy.
Author:	Miura, John T\|Johnston, Fabian M\|Thomas, James\|George, Ben\|Eastwood, Dan\|Tsai, Susan\|Christians, Kathleen K\|Turaga, Kiran K\|Gamblin, T Clark
PMID:	24844210

67.
Journal:	Tumour Biol. 2014 Sep;35(9):8721-31.
Title:	The prognostic value of ERCC1 expression in gastric cancer patients treated with platinum-based chemotherapy: a meta-analysis.
Author:	Wei, Kong-Kong\|Jiang, Lei\|Wei, Yao-Yao\|Wang, Yu-Feng\|Qian, Xuan-Kun\|Dai, Qiang\|Guan, Quan-Lin
PMID:	24870596

68.
Journal:	Carcinogenesis. 2014 Sep;35(9):2031-8.
Title:	Potentially functional variants in the core nucleotide excision repair genes predict survival in Japanese gastric cancer patients.
Author:	Li, Yangkai\|Liu, Zhensheng\|Liu, Hongliang\|Wang, Li-E\|Onodera, Hisashi\|Suzuki, Akihiro\|Suzuki, Koyu\|Wadhwa, Roopma\|Elimova, Elena\|Sudo, Kazuki\|Shiozaki, Hironari\|Estrella, Jeannelyn\|Lee, Ju-Seog\|Song, Shumei\|Tan, Dongfeng\|Ajani, Jaffer A\|Wei, Qingyi
PMID:	24990617

69.
Journal:	J Cancer Res Clin Oncol. 2014 Dec;140(12):2107-17.
Title:	Predictive value of excision repair cross-complementation group 1 expression for platinum-based chemotherapy and survival in gastric cancer: a meta-analysis.
Author:	Yao, Anqi\|Wang, You\|Peng, Xiaohong\|Ye, Rong\|Wang, Qiaoli\|Qi, Yuexiao\|Zhou, Fuxiang
PMID:	24994039

70.
Journal:	Chin J Cancer Res. 2014 Jun;26(3):323-30.
Title:	Prognostic significance of ERCC1 expression in postoperative patients with gastric cancer.
Author:	Wang, Jian\|Zhou, Xi-Qiao\|Li, Jing-Ying\|Cheng, Jian-Feng\|Zeng, Xiao-Ning\|Li, Xiao\|Liu, Ping
PMID:	25035660

71.
Journal:	J Gastrointest Oncol. 2014 Aug;5(4):253-8.
Title:	Breast cancer resistance protein (BCRP) and excision repair cross complement-1 (ERCC1) expression in esophageal cancers and response to cisplatin and irinotecan based chemotherapy.
Author:	Bharthuar, Anubha\|Saif Ur Rehman, Sana\|Black, Jennifer D\|Levea, Charles\|Malhotra, Usha\|Mashtare, Terry L\|Iyer, Renuka
PMID:	25083297

72.
Journal:	Genet Mol Res. 2014 Sep 12;13(3):7484-91.
Title:	Association of DNA repair gene polymorphisms with response to chemotherapy and prognosis of gastric cancer.
Author:	Chen, Z H\|Wang, L\|Luo, L P
PMID:	25222248

73.
Journal:	Eur J Med Res. 2014 Sep 16;19:50.
Title:	Joint detection of ERCC1, TUBB3, and TYMS guidance selection of docetaxel, 5-fluorouracil and cisplatin (DDP) individual chemotherapy in advanced gastric cancer patients.
Author:	Luo, Yushuang\|Li, Zhanquan\|Cui, Sen\|Shen, Cunfang\|Zhao, Junhui\|Wu, Milu\|Li, Yuying\|Wang, Miaozhou\|Chen, Rong\|Liu, Zhibo\|Ri-Li, Ge
PMID:	25223338

74.
Journal:	Genet Mol Res. 2014 Oct 27;13(4):8722-8.
Title:	Study on the ERCC1 gene polymorphism response to chemotherapy and prognosis of gastric cancer.
Author:	Liu, L\|Li, C H\|Jin, T F\|Xu, D Y
PMID:	25366763

75.
Journal:	Int J Clin Exp Pathol. 2014 Dec 1;7(12):8312-21. eCollection 2014.
Title:	Prognostic value of ERCC1 mRNA expression in non-small cell lung cancer, breast cancer, and gastric cancer in patients from Southern China.
Author:	Deng, Qiuhua\|Yang, Haihong\|Lin, Yongping\|Qiu, Yuan\|Gu, Xia\|He, Ping\|Zhao, Meiling\|Wang, Hui\|Xu, Yunjian\|Lin, Yunen\|Jiang, Juhong\|He, Jianxing\|Zhou, Jeff X
PMID:	25674197

76.
Journal:	Tumour Biol. 2015 Apr;36(4):3017-23.
Title:	Genetic polymorphisms of DNA repair pathways influence the response to chemotherapy and overall survival of gastric cancer.
Author:	Zhou, Jing\|Liu, Zhi-yue\|Li, Cun-bao\|Gao, Shang\|Ding, Li-hong\|Wu, Xin-lin\|Wang, Zhao-yang
PMID:	25542228

77.
Journal:	Cancer Biol Ther. 2015;16(5):764-9.
Title:	Tumor profiling of gastric and esophageal carcinoma reveal different treatment options.
Author:	Miura, John T\|Xiu, Joanne\|Thomas, James\|George, Ben\|Carron, Benjamin R\|Tsai, Susan\|Johnston, Fabian M\|Turaga, Kiran K\|Gamblin, T Clark
PMID:	25778705

78.
Journal:	Exp Ther Med. 2015 Apr;9(4):1393-1400.
Title:	Prognostic value of excision repair cross-complementation group 1 expression in gastric cancer: A meta-analysis.
Author:	Song, Peng\|Yin, Qin\|Lu, Ming\|Fu, B O\|Wang, Baolin\|Zhao, Qinghong
PMID:	25780441

79.
Journal:	Onco Targets Ther. 2015 Mar 16;8:641-8.
Title:	Association between the ERCC1 rs11615 polymorphism and clinical outcomes of oxaliplatin-based chemotherapies in gastrointestinal cancer: a meta-analysis.
Author:	Ma, Shou-Cheng\|Zhao, Yue\|Zhang, Tao\|Ling, Xiao-Ling\|Zhao, Da
PMID:	25834456

80.
Journal:	Eur J Med Res. 2015 Mar 26;20:29.
Title:	Retraction note: Joint detection of ERCC1, TUBB3, and TYMS guidance selection of docetaxel, 5-fluorouracil and cisplatin (DDP) individual chemotherapy in advanced gastric cancer patients.
Author:
PMID:	25888862

81.
Journal:	Int J Clin Exp Pathol. 2015 Apr 1;8(4):4106-12. eCollection 2015.
Title:	Genetic variability of DNA repair mechanisms influences chemotherapy outcome of gastric cancer.
Author:	Yu, Hai\|Wu, Xinghua\|Zhang, Yonggang\|Jin, Zhihong\|Li, Guoxin\|Zhao, Haiping
PMID:	26097599

82.
Journal:	Int J Clin Exp Pathol. 2015 May 1;8(5):5563-9. eCollection 2015.
Title:	Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.
Author:	Xue, Ming-Hui\|Li, Guang-Yan\|Wu, Xin-Jun\|Zhang, Chao-Xian\|Zhang, Cai-Feng\|Zhu, Kong-Xi
PMID:	26191265

83.
Journal:	Am J Transl Res. 2015 Aug 15;7(8):1429-39. eCollection 2015.
Title:	Delineation of gastric cancer subtypes by co-regulated expression of receptor tyrosine kinases and chemosensitivity genes.
Author:	Li, Shu-Chun\|Ma, Rong\|Wu, Jian-Zhong\|Xiao, Xia\|Wu, Wei\|Li, Gang\|Chen, Bo\|Sharma, Ashok\|Bai, Shan\|Dun, Bo-Ying\|She, Jin-Xiong\|Tang, Jin-Hai
PMID:	26396673

84.
Journal:	Cancer Chemother Pharmacol. 2015 Dec;76(6):1285-95.
Title:	Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junction.
Author:	Deenen, Maarten J\|Meulendijks, Didier\|Boot, Henk\|Legdeur, Marie-Cecile J C\|Beijnen, Jos H\|Schellens, Jan H M\|Cats, Annemieke
PMID:	26499900

85.
Journal:	Oncol Lett. 2015 Oct;10(4):1997-2002.
Title:	Genetic variability of DNA repair mechanisms influences treatment outcome of gastric cancer.
Author:	Ding, Changmao\|Zhang, Huiyu\|Chen, Kuisheng\|Zhao, Chunlin\|Gao, Jianbo
PMID:	26622786

86.
Journal:	Genet Mol Res. 2015 Dec 7;14(4):15921-9.
Title:	Correlation of ERCC1 expression in peripheral blood lymphocytes with outcomes of patients with gastric cancer treated with oxaliplatin-based adjuvant chemotherapy.
Author:	Zhang, Y Y\|Gu, K S\|Wu, H Y\|Yang, F\|Bu, L J\|Zhao, C C\|Zhang, Y R
PMID:	26662383

87.
Journal:	Genet Mol Res. 2015 Dec 17;14(4):17228-34.
Title:	Genetic variability of DNA repair mechanisms in chemotherapy treatment outcome of gastric cancer patients.
Author:	Zhong, G\|Li, H K\|Shan, T\|Zhang, N
PMID:	26681216

88.
Journal:	Int J Clin Exp Pathol. 2015 Oct 1;8(10):13367-73. eCollection 2015.
Title:	Genetic variability of ERCC1 genes in NER pathway influences the treatment outcome of gastric cancer.
Author:	Bai, Yu\|Wang, Lei\|Li, Guangjun\|Fang, Xiangjie\|Li, Yan\|Yang, Shujuan
PMID:	26722542

89.
Journal:	Int J Clin Exp Med. 2015 Oct 15;8(10):18375-82. eCollection 2015.
Title:	Polymorphisms of ERCC1 and XRCC1 predict the overall survival of advanced gastric cancer patients receiving oxaliplatin-based chemotherapy.
Author:	Zhang, Lijian\|Yao, Ruyong\|Fang, Shibao\|Wang, Xiuwen\|Li, Xin
PMID:	26770441

90.
Journal:	Genet Mol Res. 2015 Dec 21;14(4):17529-35.
Title:	Genetic variability of ERCC1 and ERCC2 influences treatment outcomes in gastric cancer.
Author:	Yu, W H\|Wang, Y X\|Guo, J Q\|Wang, Y L\|Zheng, J S\|Zhu, K X
PMID:	26782397

91.
Journal:	Int J Clin Exp Pathol. 2015 Nov 1;8(11):15065-71. eCollection 2015.
Title:	Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy.
Author:	Mo, Juanmei\|Luo, Min\|Cui, Jiandong\|Zhou, Shaozhang
PMID:	26823845

92.
Journal:	Tumour Biol. 2016 Feb;37(2):1753-62.
Title:	Influences of ERCC1, ERCC2, XRCC1, GSTP1, GSTT1, and MTHFR polymorphisms on clinical outcomes in gastric cancer patients treated with EOF chemotherapy.
Author:	Liu, Rujiao\|Zhao, Xiaoying\|Liu, Xin\|Chen, Zhiyu\|Qiu, Lixin\|Geng, Ruixuan\|Guo, Weijian\|He, Guang\|Yin, Jiliang\|Li, Jin\|Zhu, Xiaodong
PMID:	26314858

93.
Journal:	Oncol Res. 2016;23(1-2):35-41.
Title:	Enhancement of Chemosensitivity by Stathmin-1 Silencing in Gastric Cancer Cells In Situ and In Vivo.
Author:	Meng, Zhi-jian\|Tao, Ke
PMID:	26802649

94.
Journal:	Asian Pac J Cancer Prev. 2016;17(3):1369-72.
Title:	Investigating the Frequency of the ERCC1 Gene C8092A Polymorphism in Iranian Patients with Advanced Gastric Cancer Receiving Platinum-based Chemotherapy.
Author:	Mokmeli, Sharareh\|Tehrani, Golnaz Asaadi\|Zamiri, Reza Eghdam\|Bahrami, Tayyeb
PMID:	27039774

95.
Journal:	Int J Oncol. 2016 Jun;48(6):2693-703.
Title:	Tissue microRNAs as predictive markers for gastric cancer patients undergoing palliative chemotherapy.
Author:	Smid, David\|Kulda, Vlastimil\|Srbecka, Kristyna\|Kubackova, Dasa\|Dolezal, Jan\|Daum, Ondrej\|Kucera, Radek\|Topolcan, Ondrej\|Treska, Vladislav\|Skalicky, Tomas\|Pesta, Martin
PMID:	27081844

96.
Journal:	Oncol Lett. 2016 May;11(5):3477-3482.
Title:	Evaluation of effects of thymidylate synthase and excision repair cross-complementing 1 polymorphisms on chemotherapy outcome in patients with gastrointestinal tumors using peripheral venous blood.
Author:	Huang, Kaida\|Shen, Yan\|Zhang, Fengqi\|Wang, Shanshan\|Wei, Xiao
PMID:	27123139

97.
Journal:	Clin Oncol (R Coll Radiol). 2016 Aug;28(8):e45-51.
Title:	Molecular Biomarker Study in a Randomised Phase III Trial of Irinotecan Plus S-1 versus S-1 for Advanced Gastric Cancer (GC0301/TOP-002).
Author:	Tsuburaya, A\|Sugimoto, N\|Imamura, H\|Nishikawa, K\|Imamoto, H\|Tsujinaka, T\|Esaki, T\|Horita, Y\|Kimura, Y\|Fujiya, T\|Takayama, O\|Oono, R\|Yabusaki, H\|Taguri, M\|Morita, S\|Yamada, Y\|Tan, P\|Ninomiya, M\|Furukawa, H\|Sasako, M
PMID:	27142170

98.
Journal:	Genet Mol Res. 2016 Apr 26;15(2). pii: gmr7384.
Title:	Genetic variability of ERCC1 and ERCC2 genes involved in the nucleotide excision repair pathway influences the treatment outcome of gastric cancer.
Author:	Zheng, D L\|Tang, G D\|Chen, Y N\|Zhang, T\|Qin, M B
PMID:	27173253

99.
Journal:	Oncotarget. 2016 Jul 26;7(30):48130-48142.
Title:	Polymorphisms of multiple genes involved in NER pathway predict prognosis of gastric cancer.
Author:	Liu, Jingwei\|Deng, Na\|Xu, Qian\|Sun, Liping\|Tu, Huakang\|Wang, Zhenning\|Xing, Chengzhong\|Yuan, Yuan
PMID:	27340861

100.
Journal:	Oncotarget. 2016 Aug 2;7(31):49322-49333.
Title:	Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients.
Author:	Szasz, A Marcell\|Lanczky, Andras\|Nagy, Adam\|Forster, Susann\|Hark, Kim\|Green, Jeffrey E\|Boussioutas, Alex\|Busuttil, Rita\|Szabo, Andras\|Gyorffy, Balazs
PMID:	27384994

101.
Journal:	Gan To Kagaku Ryoho. 2016 Jul;43(7):889-92.
Title:	[Pathological Complete Response of Advanced Gastric Cancer after Docetaxel and S-1 Combination Neoadjuvant Chemotherapy-A Case Report].
Author:	Arisaka, Sayaka\|Kosaka, Ryuji\|Kunisaki, Chikara\|Ichikawa, Yasushi\|Akiyama, Hirotoshi\|Furuya, Mitsuko\|Ohashi, Kenichi\|Endo, Itaru
PMID:	27431635

102.
Journal:	Oncotarget. 2016 Aug 23;7(34):55449-55457.
Title:	ABCC2-24C > T polymorphism is associated with the response to platinum/5-Fu-based neoadjuvant chemotherapy and better clinical outcomes in advanced gastric cancer patients.
Author:	Li, Ziyu\|Xing, Xiaofang\|Shan, Fei\|Li, Shuangxi\|Li, Zhongwu\|Xiao, Aitang\|Xing, Zhaodong\|Xue, Kan\|Li, Zhemin\|Hu, Ying\|Jia, Yongning\|Miao, Rulin\|Zhang, Lianhai\|Bu, Zhaode\|Wu, Aiwen\|Ji, Jiafu
PMID:	27487151

103.
Journal:	Am J Transl Res. 2016 Dec 15;8(12):5729-5740. eCollection 2016.
Title:	Tumor profiling of co-regulated receptor tyrosine kinase and chemoresistant genes reveal different targeting options for lung and gastroesophageal cancers.
Author:	Wu, Jianzhong\|Li, Shuchun\|Ma, Rong\|Sharma, Ashok\|Bai, Shan\|Dun, Boying\|Cao, Haixia\|Jing, Changwen\|She, Jinxiong\|Feng, Jifeng
PMID:	28078044

104.
Journal:	Oncol Res. 2016 Jan 21;23(1):35-41.
Title:	Enhancement of Chemosensitivity by Stathmin-1 Silencing in Gastric Cancer Cells In Situ and In Vivo.
Author:	Meng, Zhi-Jian\|Tao, Ke
PMID:	29021019

105.
Journal:	Pharmacogenomics J. 2017 Oct;17(5):441-451.
Title:	Pharmacogenetic variants associated with outcome in patients with advanced gastric cancer treated with fluoropyrimidine and platinum-based triplet combinations: a pooled analysis of three prospective studies.
Author:	Meulendijks, D\|Rozeman, E A\|Cats, A\|Sikorska, K\|Joerger, M\|Deenen, M J\|Beijnen, J H\|Schellens, J H M
PMID:	27995989

106.
Journal:	BMC Gastroenterol. 2017 Jan 5;17(1):2.
Title:	Clinical significance of UGT1A1 polymorphism and expression of ERCC1, BRCA1, TYMS, RRM1, TUBB3, STMN1 and TOP2A in gastric cancer.
Author:	Cao, Yongkuan\|Zhang, Guohu\|Wang, Peihong\|Zhou, Jun\|Gan, Wei\|Song, Yaning\|Huang, Ling\|Zhang, Ya\|Luo, Guode\|Gong, Jiaqing\|Zhang, Lin
PMID:	28056823

107.
Journal:	Cancer Invest. 2017 Feb 7;35(2):85-91.
Title:	Higher Expression of ERCC1 May Be Associated with Resistance to Adjuvant Platinum-Based Chemotherapy in Gastric Cancer.
Author:	Wan, Jiayi\|Chao, Lin\|Lee, Arier C\|Chen, Qi
PMID:	28102711

108.
Journal:	Mol Carcinog. 2017 Dec;56(12):2706-2717.
Title:	Functional genetic variants of XRCC4 and ERCC1 predict survival of gastric cancer patients treated with chemotherapy by regulating the gene expression.
Author:	Cheng, Lei\|Qiu, Lixin\|Wang, Mengyun\|Zhang, Ruoxin\|Sun, Menghong\|Zhu, Xiaodong\|Wang, Yanong\|Wei, Qingyi
PMID:	28796378

109.
Journal:	Mutagenesis. 2017 Jul 1;32(4):471-478.
Title:	The intricate interplay between MSI and polymorphisms of DNA repair enzymes in gastric cancer H.pylori associated.
Author:	Silva-Fernandes, Isabelle Joyce de Lima\|Oliveira, Emanuele Silva de\|Santos, Juliana Carvalho\|Ribeiro, Marcelo Lima\|Ferrasi, Adriana Camargo\|Pardini, Maria Ines de Moura Campos\|Burbano, Rommel Mario Rodriguez\|Rabenhorst, Silvia Helena Barem
PMID:	28927196

110.
Journal:	Cancer Biomark. 2018 Feb 6;21(2):439-447.
Title:	Methods and significance of the combined detection of HER2 gene amplification and chemosensitivity in gastric cancer.
Author:	Wang, Yang-Kun\|Wang, Su-Nan\|Li, Ying-Ying\|Wang, Gong-Ping\|Yun, Tian\|Zhu, Chao-Ya\|Yang, Bin-Feng\|Li, Cong-Yang\|Jiang, Bo\|Zhu, Mei-Ling
PMID:	29125480

111.
Journal:	Onco Targets Ther. 2017 Dec 20;11:1-8.
Title:	ERCC1 rs3212986 A/C polymorphism is not associated with chemotherapy treatment outcomes in gastric cancer patients: evidence from 11 publications in Chinese populations.
Author:	Tang, Weiwei\|Wang, Hanjin\|Wang, Yuemei\|Wang, Xiaowei
PMID:	29302191

112.
Journal:	Biol Pharm Bull. 2018;41(3):360-367.
Title:	Association of DNA Repair and Drug Transporter in Relation to Chemosensitivity in Primary Culture of Thai Gastric Cancer Patients.
Author:	Wongsirisin, Pattama\|Limpakan Yamada, Sirikan\|Yodkeeree, Supachai\|Punfa, Wanisa\|Limtrakul, Pornngarm
PMID:	29491212

113.
Journal:	Cancer Manag Res. 2018 Apr 12;10:765-774.
Title:	Genetic variants in the nucleotide excision repair pathway genes and gastric cancer susceptibility in a southern Chinese population.
Author:	He, Jing\|Zhuo, Zhen-Jian\|Zhang, Anqi\|Zhu, Jinhong\|Hua, Rui-Xi\|Xue, Wen-Qiong\|Zhang, Shao-Dan\|Zhang, Jiang-Bo\|Li, Xi-Zhao\|Jia, Wei-Hua
PMID:	29695933

114.
Journal:	J Cell Biochem. 2018 Jul 16.
Title:	Effect of 5-fluorouracil on excision repair cross-complementing 1 expression and consequent cytotoxicity regulation in human gastric cancer cells.
Author:	Liu, Jing-Lan\|Huang, Wen-Shih\|Lee, Ko-Chao\|Tung, Shui-Yi\|Chen, Cheng-Nan\|Chang, Shun-Fu
PMID:	30011079

115.
Journal:	Cancer Res Treat. 2018 Sep 27. pii: crt.2018.331.
Title:	Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial.
Author:	Kim, Min Hwan\|Zhang, Xianglan\|Jung, Minkyu\|Jung, Inkyung\|Park, Hyung Soon\|Beom, Seung-Hoon\|Kim, Hyo Song\|Rha, Sun Young\|Kim, Hyunki\|Choi, Yoon Young\|Son, Taeil\|Kim, Hyoung-Il\|Cheong, Jae-Ho\|Hyung, Woo Jin\|Noh, Sung Hoon\|Chung, Hyun Cheol
PMID:	30282452